TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
TRDA fundamentals
Entrada Therapeutics (TRDA) released its earnings on Aug 6, 2025: revenue was 2.00M (YoY -97.89%), missed estimates; EPS was -1.04 (YoY -167.10%), missed estimates.
Revenue / YoY
2.00M
-97.89%
EPS / YoY
-1.04
-167.10%
Report date
Aug 6, 2025
EPS
Revenue
Revenue & Expenses
TRDA has released its 2025 Q3 earnings report, with revenue of 1.61M, reflecting a YoY change of -91.75%, and net profit of -44.13M, showing a YoY change of -214.52%. The Sankey diagram below clearly presents TRDA's revenue sources and cost distribution.
Key Indicators
Entrada Therapeutics (TRDA) key financial stats and ratios, covering profitability, financial health, and leverage.
Entrada Therapeutics (TRDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Entrada Therapeutics (TRDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Entrada Therapeutics (TRDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Entrada Therapeutics (TRDA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Entrada Therapeutics (TRDA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Entrada Therapeutics next quarter?What were the key takeaways from Entrada Therapeutics’s earnings call?What is Entrada Therapeutics's latest dividend and current dividend yield?What is Entrada Therapeutics's gross profit margin?Did Entrada Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Entrada Therapeutics's revenue and profit?What were the key takeaways from Entrada Therapeutics's earnings call?What is the revenue and EPS growth rate for Entrada Therapeutics year over year?
